Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Extradition process against 4 Sterling Biotech promoters initiated: ED tells courtExtradition process against 4 Sterling Biotech promoters initiated: ED tells court
    Zydus gets tentative USFDA nod to generic Esomeprazole Magnesium delayed release capsulesZydus gets tentative USFDA nod to generic Esomeprazole Magnesium delayed release capsules
    Glaxo Smith Kline Chairman Philip Hampton to step downGlaxo Smith Kline Chairman Philip Hampton to step down
    Why is Fortis buying the Assets of Singapore listed Trust: ReportWhy is Fortis buying the Assets of Singapore listed Trust: Report
    Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: ReportAster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report
    Wockhardt gets USFDA nod for generic Imatinib Mesylate tabletsWockhardt gets USFDA nod for generic Imatinib Mesylate tablets
    Series of Recall: Lupin, Sun pharma, Glenmark recall products in USSeries of Recall: Lupin, Sun pharma, Glenmark recall products in US
    Shilpa Medicare gets USFDA approval for Imatinib Mesylate TabletsShilpa Medicare gets USFDA approval for Imatinib Mesylate Tablets
    Lilly Lartruvo fails key trial, will no longer be prescribedLilly Lartruvo fails key trial, will no longer be prescribed
    Sun pharma seeks SEBI intervention after allegations of unfair trade practicesSun pharma seeks SEBI intervention after allegations of unfair trade practices
    HUL expects to complete merger with GSK Consumer Healthcare in 2019HUL expects to complete merger with GSK Consumer Healthcare in 2019
    Teva Pharma receives US FDA approval for generic SabrilTeva Pharma receives US FDA approval for generic Sabril
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok